Cart
sales@molnova.com
Kinase Domain of Insulin Receptor (2)
CAS No. ———
Kinase Domain of Insulin Receptor (2)( ——— )
Catalog No. M41560 CAS No. ———
Kinase Domain of Insulin Receptor (2)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKinase Domain of Insulin Receptor (2)
-
NoteResearch use only, not for human use.
-
Brief DescriptionKinase Domain of Insulin Receptor (2)
-
DescriptionKinase Domain of Insulin Receptor (2)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1702.77
-
Molecular FormulaC72H108N19O27P
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Cenobamate
Cenobamate (YKP-3089, YKP3089) is a potential anti-seizure agent with currently unknown mechanisms of action.
-
NAV-2729
NAV-2729 inhibits six ArfGEFs (human ARNO, EFA6, BIG1, and BRAG2 and Legionella and Rickettsia RalF), the strongest effects being against BRAG2, Arf1 and Arf6.
-
E75, Her - 2/neu (36...
E75, Her - 2/neu (369 - 377)
